Edouard-Jules Laforgue

ggfggfff t
47
Documents

Publications

Publications

Deposit thumbnail

ABCB1, SLC22A1, COMT, and OPRM1 genotypes: Study of their influence on plasma methadone levels and clinical response to methadone maintenance treatment in opioid use disorder

Abd El Kader Ait Tayeb , Edouard‐jules Laforgue , Benoit Schreck , Marie Grall‐bronnec , Jean‐benoit Hardouin et al.

Fundamental & Clinical Pharmacology, 2025, 39 (3), pp.e70013. ⟨10.1111/fcp.70013⟩

Article dans une revue hal-05099112v1
Deposit thumbnail

Drugs associated with behavioral addictions: Real world analysis using the WHO pharmacovigilance database

Louis Asselin , Edouard-Jules Laforgue , Mélanie Duval , Bruno Revol , Gwenaëlle Veyrac et al.

Therapies, 2025, S0040-5957 (25), pp.00104-0. ⟨10.1016/j.therap.2025.07.002⟩

Article dans une revue hal-05392660v1
Deposit thumbnail

SONOPS Multicentre Cross-Sectional Study

Mélanie Duval , Maud Rodney , Morgane Rousselet , Choosie Jaquin , Elsa Garot et al.

International Dental Journal, 2025, ⟨10.1016/j.identj.2025.02.007⟩

Article dans une revue hal-04955700v1
Deposit thumbnail

Delphi Consensus Among French Obesity Experts on Clinical Recommendations for Drug Prescription in Patients With Severe Obesity

Sarah Berdot , Germain Perrin , Emmanuel Disse , Armelle Arnoux , Eric Bertin et al.

Obesity Reviews, 2025, 26 (12), pp.e13977. ⟨10.1111/obr.13977⟩

Article dans une revue hal-05228358v1
Deposit thumbnail

“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose

Aurélie Aquizerate , Morgane Rousselet , Axel Cochard , Marylène Guerlais , Marie Gerardin et al.

Harm Reduction Journal, 2024, 21 (1), pp.20. ⟨10.1186/s12954-024-00941-y⟩

Article dans une revue hal-04765025v1
Deposit thumbnail

A revisited version of the disputatio for pharmacological training: An educational study

Louise Carton , Perle Totoson , Edouard-Jules Laforgue , Jean-Marc Pelerin , Thomas Portier-Feunteun et al.

Therapies, 2024, 79 (4), pp.435-441. ⟨10.1016/j.therap.2023.10.016⟩

Article dans une revue hal-04805817v1
Deposit thumbnail

ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder—the influence of impulsivity as a mediating factor

Auxane Beslot , Marie Grall-Bronnec , Marianne Balem , Benoît Schreck , Edouard-Jules Laforgue et al.

Harm Reduction Journal, 2024, 21 (1), pp.165. ⟨10.1186/s12954-024-01079-7⟩

Article dans une revue hal-04717296v1

ESCAPE study: Cannabidiol use in patients treated for substance use disorders, prevalence of use and characteristics of users.

Mélanie Duval , Marion Istvan , Morgane Rousselet , Edouard-Jules Laforgue , Marie Grall-Bronnec et al.

European Addiction Research, 2024, pp.1-20. ⟨10.1159/000541887⟩

Article dans une revue hal-04824065v1

Thromboembolic complications following recreational use of nitrous oxide: A French Addictovigilance alert

Caroline Victorri-Vigneau , Marylène Guerlais , Emmanuelle Jaulin , Edouard-Jules Laforgue , Marc-Antoine Pistorius

Thrombosis Research, 2024, 241, pp.109096. ⟨10.1016/j.thromres.2024.109096⟩

Article dans une revue hal-04785734v1
Deposit thumbnail

Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observational STIGMA study

Mélanie Pinhal , Benoît Schreck , Juliette Leboucher , Caroline Victorri-Vigneau , Edouard-Jules Laforgue et al.

Addiction Science and Clinical Practice, 2024, 19, pp.74. ⟨10.1186/s13722-024-00506-1⟩

Article dans une revue hal-04994166v1

Cannabinoid Hyperemesis Syndrome Presumed Secondary to CBD Use: A Case Report

Emilie Lefebvre , Luc Simons , Mélanie Duval , Edouard Laforgue , Caroline Victorri-Vigneau

Journal of Addiction Medicine, 2024, ⟨10.1097/ADM.0000000000001378⟩

Article dans une revue hal-04792448v1

Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database

Julien Li , Yoann Zelmat , Wilhelm Storck , Edouard Laforgue , Antoine Yrondi et al.

Journal of Affective Disorders, 2024, 350, pp.452-467. ⟨10.1016/j.jad.2024.01.119⟩

Article dans une revue hal-04789390v1
Deposit thumbnail

Physicians, pharmacists and take-home naloxone: What practices? The SINFONI study

Mélanie Duval , Aurélie Aquizerate , Emmanuelle Jaulin , Morgane Rousselet , Emmanuelle Kuhn et al. Article dans une revue hal-04765493v1

Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database

Marion Istvan , Mélanie Duval , Karl Hodel , Aurélie Aquizerate , Anicet Chaslerie et al.

European Archives of Psychiatry and Clinical Neuroscience, 2024, ⟨10.1007/s00406-024-01774-3⟩

Article dans une revue hal-04792516v1
Deposit thumbnail

Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data

Edouard-Jules Laforgue , Marion Istvan , Anicet Chaslerie , Pascal Artarit , Geneviève Vallot et al.

Epidemiology and Psychiatric Sciences, 2023, 32, pp.e59. ⟨10.1017/S2045796023000732⟩

Article dans une revue inserm-04215734v1

New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session

Benoît Schreck , Marion Istvan , Marylène Guerlais , Edouard-Jules Laforgue , Marie Gérardin et al.

Current Drug Metabolism, 2023, 24 (2), pp.80-91. ⟨10.2174/1389200224666230228103922⟩

Article dans une revue istex hal-04795180v1
Deposit thumbnail

Nitrous oxide: a unique official French addictovigilance national survey

Marylène Guerlais , Aurélie Aquizerate , Arthur Lionnet , Amélie Daveluy , Mélanie Duval et al.

Frontiers in Public Health, 2023, 11, pp.1167746. ⟨10.3389/fpubh.2023.1167746⟩

Article dans une revue hal-04765021v1
Deposit thumbnail

Evolution of the Addictovigilance Signal of Zopiclone: A 2014–2020 National Follow-up Study

Aurélie Aquizerate , Edouard-Jules Laforgue , Marion Istvan , Morgane Rousselet , Marie Gérardin et al.

International Journal of Mental Health and Addiction, 2023, ⟨10.1007/s11469-023-01078-y⟩

Article dans une revue hal-04795227v1
Deposit thumbnail

French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change

Aurélie Aquizerate , Edouard-Jules Laforgue , Marion Istvan , Morgane Rousselet , Marie Gerardin et al.

European Journal of Public Health, 2023, 33 (2), pp.169-175. ⟨10.1093/eurpub/ckad003⟩

Article dans une revue hal-04765007v1

Nitrous oxide in France: Evolution of complications reported to the French monitoring system in the context of information from health authorities and regulatory measures

Marylène Guerlais , Aurélie Aquizerate , Amélie Daveluy , Arthur Lionnet , Marie Gerardin et al.

International Journal of Drug Policy, 2023, pp.104172. ⟨10.1016/j.drugpo.2023.104172⟩

Article dans une revue hal-04794897v1

Efficacy and Safety of Electroconvulsive Therapy in Patients With Deep Brain Stimulation

Nicolas Bukowski , Andrew Laurin , Edouard Laforgue , Cécile Preterre , Tiphaine Rouaud et al.

Journal of ECT, 2022, 38 (3), pp.e29-e40. ⟨10.1097/YCT.0000000000000828⟩

Article dans une revue hal-04783913v1
Deposit thumbnail

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior

Marion Istvan , Benoît Schreck , Marie Mainguy , Pascale Jolliet , Marie Grall-Bronnec et al.

Journal of Clinical Medicine, 2022, 11 (8), pp.2176. ⟨10.3390/jcm11082176⟩

Article dans une revue hal-03678956v1
Deposit thumbnail

How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study

Morgane Guillou Landreat , Antoine Dany , Gaëlle Challet-Bouju , Edouard-Jules Laforgue , Jennifer Cholet et al.

Harm Reduction Journal, 2022, 19 (1), pp.31. ⟨10.1186/s12954-022-00608-6⟩

Article dans une revue hal-03629554v1
Deposit thumbnail

Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users

Edouard-Jules Laforgue , Morgane Rousselet , Antoine Claudon , Aurélie Aquizerate , Pascale Jolliet et al.

International Journal of Environmental Research and Public Health, 2022, 19 (15), pp.8920. ⟨10.3390/ijerph19158920⟩

Article dans une revue hal-04764984v1
Deposit thumbnail

Evolution of sexual functioning of men through treated and untreated depression

É-J Laforgue , G. Busnel , D. Lauzeille , M. Bronnec , Clémence Cabelguen et al.

L'Encéphale, 2022, ⟨10.1016/j.encep.2021.06.008⟩

Article dans une revue hal-03406872v1

Did the pattern of use of zolpidem change since the enforcement of a new prescription rule? A latent class analysis using the French health insurance database

Marion Istvan , Morgane Rousselet , Edouard-Jules Laforgue , Marylène Guerlais , Marie Gérardin et al.

Expert Opinion on Drug Safety, 2022, 21 (9), pp.1225-1234. ⟨10.1080/14740338.2022.2047930⟩

Article dans une revue hal-04796549v1

CYP1A2 and tobacco interaction

Malcolm Barrangou-Poueys-Darlas , Marylène Guerlais , Edouard-Jules Laforgue , Ronan Bellouard , Marion Istvan et al.

Drug Metabolism Reviews, 2021, 53 (1), pp.30-44. ⟨10.1080/03602532.2020.1859528⟩

Article dans une revue hal-03407082v1

ZORRO: When the mask falls off—Comment

Marion Istvan , Edouard-Jules Laforgue , Marylène Guerlais , Pascale Jolliet , Caroline Victorri-Vigneau

British Journal of Clinical Pharmacology, 2021, ⟨10.1111/bcp.15086⟩

Article dans une revue hal-03406898v1
Deposit thumbnail

Regulatory Framework Implementation for the Prescription of Zolpidem in France, What Impact in the Older People?

Alexandra Jobert , Marion Istvan , Edouard-Jules Laforgue , Benoît Schreck , Caroline Victorri-Vigneau

International Journal of Environmental Research and Public Health, 2021, 18, ⟨10.3390/ijerph182212099⟩

Article dans une revue hal-03445931v1

What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance database

Edouard-Jules Laforgue , Marion Istvan , Marylène Guerlais , Anicet Chaslerie , Pascal Artarit et al.

Expert Opinion on Drug Safety, 2021, 20 (10), pp.1247-1256. ⟨10.1080/14740338.2021.1939304⟩

Article dans une revue hal-03406940v1

A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study)

Virginie Moulier , Mohamed Wassim Krir , Marine Dalmont , Olivier Guillin , Maud Rothärmel et al.

Trials, 2021, 2021 (22), pp.284. ⟨10.1186/s13063-021-05227-3⟩

Article dans une revue hal-05322770v1

Slam Practice :

Benoît Schreck , Caroline Victorri-Vigneau , Marylène Guerlais , Edouard-Jules Laforgue , Marie Grall-Bronnec

European Addiction Research, 2021, 27 (3), pp.161-178. ⟨10.1159/000511897⟩

Article dans une revue hal-04994156v1

Change in the regulatory framework for zolpidem

Marion Istvan , Pascal Caillet , Morgane Rousselet , Marylène Guerlais , Edouard-Jules Laforgue et al.

British Journal of Clinical Pharmacology, 2021, 87 (8), pp.3310-3319. ⟨10.1111/bcp.14753⟩

Article dans une revue hal-03407064v1

Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?

Alexandra Jobert , Edouard Laforgue , Marie Grall-Bronnec , Morgane Rousselet , Morgane Péré et al.

European Journal of Clinical Pharmacology, 2021, 77 (2), pp.171-177. ⟨10.1007/s00228-020-03007-7⟩

Article dans une revue hal-03244134v1
Deposit thumbnail

What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report

Morgane Guillou-Landréat , Antoine Dany , Gaëlle Challet-Bouju , Edouard Laforgue , Juliette Leboucher et al.

International Journal of Environmental Research and Public Health, 2021, 18 (4), pp.1425. ⟨10.3390/ijerph18041425⟩

Article dans une revue hal-03211107v1

Are Seniors Dependent on Benzodiazepines?

Caroline Victorri-Vigneau , Edouard-Jules Laforgue , Marie Grall-Bronnec , Morgane Guillou-Landreat , Morgane Rousselet et al.

Clinical Pharmacology and Therapeutics, 2021, 109 (2), pp.528-535. ⟨10.1002/cpt.2025⟩

Article dans une revue hal-03407111v1

Cannabinoid Hyperemesis Syndrome Among Pregnant Women

Edouard-Jules Laforgue , Aurore Lesage , Benoît Schreck , Marylène Guerlais , Caroline Victorri-Vigneau

Journal of Studies on Alcohol and Drugs, 2020, 81 (6), pp.824-825. ⟨10.15288/jsad.2020.81.824⟩

Article dans une revue hal-03407086v1
Deposit thumbnail

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness

Audrey Verholleman , Caroline Victorri-Vigneau , Edouard Laforgue , Pascal Derkinderen , Celine Verstuyft et al.

International Journal of Molecular Sciences, 2020, 21 (8), pp.3002. ⟨10.3390/ijms21083002⟩

Article dans une revue hal-03159491v1
Deposit thumbnail

Do Older People Know Why They Take Benzodiazepines? A National French Cross-Sectional Survey of Long-Term Consumers

Edouard‐jules Laforgue , Alexandra Jobert , Morgane Rousselet , Marie Grall-Bronnec , Pascale Jolliet et al.

International Journal of Geriatric Psychiatry, 2020, 35 (8), pp.870-876. ⟨10.1002/gps.5307⟩

Article dans une revue hal-03159473v1
Deposit thumbnail

Cathinone Use Disorder in the Context of Slam Practice

Benoît Schreck , Marylène Guerlais , Edouard Laforgue , Célia Bichon , Marie Grall-Bronnec et al.

Frontiers in Psychiatry, 2020, 11, ⟨10.3389/fpsyt.2020.00705⟩

Article dans une revue hal-04063101v1
Deposit thumbnail

Prevalence of Coaddictions and Rate of Successful Treatment Among a French Sample of Opioid-Dependent Patients With Long-Term Opioid Substitution Therapy: The OPAL Study

Marie Grall-Bronnec , Edouard Laforgue , Gaëlle Challet-Bouju , Jennyfer Cholet , Jean-Benoit Hardouin et al.

Frontiers in Psychiatry, 2019, 10, pp.726. ⟨10.3389/fpsyt.2019.00726⟩

Article dans une revue hal-03158795v1

Relevance of CYP2B6 and CYP2D6 Genotypes to Methadone Pharmacokinetics and Response in the OPAL Study

Caroline Victorri-Vigneau , Céline Verstuyft , Régis Bouquié , Edouard Laforgue , Jean-Benoit Hardouin et al.

British Journal of Clinical Pharmacology, 2019, 85 (7), pp.1538-1543. ⟨10.1111/bcp.13936⟩

Article dans une revue hal-03158829v1

Management of Emergency Electroconvulsive Therapy in the Intensive Care Unit for Life-Threatening Psychiatric Conditions: A Case Series

Samuel Bulteau , Edouard Laforgue , Loïc Chimot , Romain Dumont , Olivier Loutrel et al.

The journal of ECT, 2018, 34 (1), pp.55-59. ⟨10.1097/YCT.0000000000000451⟩

Article dans une revue hal-03158600v1

Bipolar Disorder and Adherence: Implications of Manic Subjective Experience on Treatment Disruption

Samuel Bulteau , Marie Grall-Bronnec , Pierre-Yves Bars , Edouard Laforgue , François Etcheverrigaray et al.

Patient Preference and Adherence, 2018, 12, pp.1355-1361. ⟨10.2147/PPA.S151838⟩

Article dans une revue hal-03158599v1

Dynamics of Postural Control during Repetitive Transcranial Magnetic Stimulation in an Adult with Major Depressive Disorder

Thibault Deschamps , Anne Sauvaget , Edouard Laforgue , Samuel Bulteau , Véronique Thomas-Ollivier

Australian and New Zealand Journal of Psychiatry, 2018, 52 (3), pp.291-293. ⟨10.1177/0004867417742520⟩

Article dans une revue hal-03158607v1

Efficacy of Intermittent Theta Burst Stimulation (iTBS) and 10-Hz High-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment-Resistant Unipolar Depression: Study Protocol for a Randomised Controlled Trial

Samuel Bulteau , Véronique Sébille , Guillemette Fayet , Veronique Thomas-Ollivier , Thibault Deschamps et al.

Trials, 2017, 18 (1), pp.17. ⟨10.1186/s13063-016-1764-8⟩

Article dans une revue hal-03158125v1